CoChat

Retroviral vector‐producing mesenchymal stem cells for targeted suicide cancer gene therapy

Uchibori, Ryosuke, Okada, Takashi, Ito, Takayuki, Urabe, Masashi, Mizukami, Hiroaki, Kume, Akihiro, Ozawa, Keiya · 2009 · The Journal of Gene Medicine
Cited by 128

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background: Mesenchymal stem cells (MSCs) are a promising vehicle for targeted cancer gene therapy because of their potential of tumor tropism. For efficient therapeutic application, we developed retroviral vector‐producing MSCs that enhance tumor transduction via progeny vector production. Methods: Rat bone marrow‐derived MSCs were nucleofected with the proviral plasmids (vesicular stomatitis virus‐G protein‐pseudotyped retroviral vector components) (VP‐MSCs) or pLTR plasmid alone (non‐VP‐MSCs). The luciferase‐based in vivo imaging system was used to assess gene expression periodically. To evaluate the anticancer effects, we administered MSCs expressing herpes simplex virus‐thymidine kinase (HSV‐tk) into the left ventricular cavity of nude mice engrafted with 9L glioma cells subcutaneously. Results: In vivo imaging revealed that administration of luciferase‐expressing non‐VP‐MSCs enhanced the bioluminescence signal at the inoculation sites of 9L cells, whereas no accumulation was observed in mice at the site of the control Rat‐1 fibroblasts. Compared to non‐VP‐MSCs, the administration of VP‐MSCs resulted in significant augmentation of the signal with an increase in transgene copy number. Immunohistochemical analysis showed marked luciferase expression at the tumor periphery in mice injected with VP‐MSCs, whereas little expression was detected in those injected with non‐VP‐MSCs. Under the continuous infusion of ganciclovir, systemic administration of VP‐MSCs expressing HSV‐tk suppressed tumor growth more effectively than non‐VP‐MSC administration, whereas no anticancer effect was observed without ganciclovir treatment. Furthermore, VP‐MSC administration caused no transgene transduction in the normal tissues and organs. Conclusions: VP‐MSCs accumulated at the site of tumors after intravascular injection in tumor‐bearing mice, followed by in situ gene transfer to tumors without transduction of normal organs. When applied to the HSV‐tk/ganciclovir suicide gene therapy, more efficient tumor growth suppression was observed using VP‐MSCs compared to non‐VP‐MSCs. This VP‐MSC‐based system has great potential for improved cancer gene therapy. Copyright © 2009 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jgm.1313

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 12

  1. 10.1038/nm1297-1354 · DOI · Paper page
  2. 10.1089/104303400750038499 · DOI · Paper page
  3. 10.1158/0008-5472.CAN-04-1874 · DOI · Paper page
  4. 10.1016/j.jaut.2007.12.008 · DOI
  5. 10.1038/sj.bmt.1704400 · DOI · Paper page
  6. 10.1016/S0092-8674(00)81683-9 · DOI · Paper page
  7. 10.1007/978-3-540-68976-8_12 · DOI · Paper page
  8. 10.1016/j.bbmt.2005.01.005 · DOI · Paper page
  9. Studeny M, 2002, Bone marrow‐derived mesenchymal stem cells as vehicles for interferon‐beta delivery into tumors, Cancer Res, 62, 3603
  10. 10.1002/jgm.490 · doi:10.1002/jgm.490
  11. 10.1634/stemcells.2005-0198 · DOI
  12. 10.1089/scd.2005.14.252 · DOI · Paper page

Cited by

See all 128

Metadata

Authors
Uchibori, R., Okada, T., Ito, T., Urabe, M., Mizukami, H., Kume, A., & Ozawa, K.
Venue
The Journal of Gene Medicine
Publisher
Wiley
Published
2009-03-09
Volume
11
Issue
5
Pages
373-381
ISSN
  • 1099-498X (ISSN-L)
  • 1521-2254
OpenAlex
W2019713216
Cited by
128
References
5
FWCI
6.95
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Retroviral vector‐producing mesenchymal stem cells for targeted suicide cancer gene therapy. https://app.cochat.ai/papers/10.1002/jgm.1313
The paper
Uchibori, R., Okada, T., Ito, T., Urabe, M., Mizukami, H., Kume, A., & Ozawa, K. (2009). Retroviral vector‐producing mesenchymal stem cells for targeted suicide cancer gene therapy. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.1313

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.